Recent data reported by the International Diabetes Federation (IDF) in 2021 have demonstrated that the global prevalence of diabetes was estimated at 10.5% (approximately 537 million people) ( Glucagon-like peptide-1 (GLP-1) is an insulin-promoting hormone and can enhance glucose-dependent insulin secretion, inhibit glucagon secretion and delay gastric emptying
Studies (101,102) have indicated that the GSH/GSSG redox status serves as a vital indicator of tumor programmed cell death, consistently associating programmed cell death with a decrease in the GSH/GSSG ratio
- BPC 157: Science-Backed Uses, Benefits, Dosage, and Safety - Unlocking Healing Potential: The Benefits of BPC-157 Peptide
New research presented at the Endocrine Societys 2025 Annual Meeting (ENDO 2025) has revealed that tirzepatidea medication originally developed for weight loss and type 2 diabetesmay offer surprising benefits for men suffering from both obesity and functional hypogonadism (low testosterone due to metabolic causes)
Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
Some are mild, while others can be intense